Most Recent

A 3-D carbon nanotube mesh enables rat spinal tissue sections to reconnect in culture.

2 Comments

image: 23andMe Markets Genome Kits to Researchers

23andMe Markets Genome Kits to Researchers

By | July 14, 2016

A 3-D carbon nanotube mesh enables rat spinal tissue sections to reconnect in culture.

0 Comments

image: Considering Gene Editing

Considering Gene Editing

By | July 12, 2016

A 3-D carbon nanotube mesh enables rat spinal tissue sections to reconnect in culture.

0 Comments

A 3-D carbon nanotube mesh enables rat spinal tissue sections to reconnect in culture.

1 Comment

image: A New Way to ID Targets of RNA-Binding Proteins

A New Way to ID Targets of RNA-Binding Proteins

By | July 1, 2016

A 3-D carbon nanotube mesh enables rat spinal tissue sections to reconnect in culture.

0 Comments

image: How High Fat and Insulin Levels May Lead to Diabetes

How High Fat and Insulin Levels May Lead to Diabetes

By | July 1, 2016

A 3-D carbon nanotube mesh enables rat spinal tissue sections to reconnect in culture.

0 Comments

image: Metabolic Syndrome, Research, and Race

Metabolic Syndrome, Research, and Race

By | July 1, 2016

A 3-D carbon nanotube mesh enables rat spinal tissue sections to reconnect in culture.

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | July 1, 2016

A 3-D carbon nanotube mesh enables rat spinal tissue sections to reconnect in culture.

1 Comment

image: The Genetic Components of Rare Diseases

The Genetic Components of Rare Diseases

By | July 1, 2016

A 3-D carbon nanotube mesh enables rat spinal tissue sections to reconnect in culture.

0 Comments

image: What Causes Type 2 Diabetes?

What Causes Type 2 Diabetes?

By | July 1, 2016

A 3-D carbon nanotube mesh enables rat spinal tissue sections to reconnect in culture.

9 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech